A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

Y. Hattori, W. Du, T. Yamada, D. Ichikawa, S. Matsunami, M. Matsushita

Research output: Contribution to journalLetter

5 Citations (Scopus)
Original languageEnglish
Article numbere115
JournalBlood cancer journal
Volume3
Issue number5
DOIs
Publication statusPublished - 2013 May

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this